when were glp 1 drugs approved History of glucagon-like peptide-1 receptor agonists Figure 2, Health Canada Approval
Description
The effectiveness of unimolecular peptide triagonists in reversed diet-induced steatohepatitis in mice was then confirmed by Jall et al

doi: 10.1111/jdi.12275 75 NauckMRizzoMJohnsonABosch-TrabergHMadsenJCariouB

F., & STEP 1 Study Group (2021)

Consistent with this concept, GLP-1RAs have been shown to directly modulate immune responses by reducing the secretion of key pro-inflammatory cytokines such as IL-6 and TNF-, which are central drivers of inflammation in both PsO and PsA (70, 71)

Over a 14-day treatment period, GLP-1MK-801 synergistically lowered body weight compared with the dose-matched monotherapies and produced a vehicle-corrected weight loss of 23.2% (Fig

However, we also have a constant, low level of circulating GLP-1 even when fasting.[ref][ref] This directly ties into the gut microbiome
